NCT02410746

Brief Summary

Effective postoperative pain control is an essential component of surgery. Adequate analgesia improves patient comfort and satisfaction, thereby permitting earlier mobilisation, faster recovery and less likelihood of complications.The majority of surgeons will place 10ml of local anaesthetic into the breast pocket or inject it into the breast skin following breast surgery. A more specific technique is to identify the nerves supplying the breast and put the local anaesthetic directly around them (Pec block). This nerve block has recently been described and is increasingly being used by anaesthetists for surgery under local anaesthetic or for post-operative analgesia. It has been shown to provide better and more specific pain relief in several studies. Anaesthetists use an ultrasound machine to identify the anatomical landmarks for the nerves and they inject into the vicinity. They do not have direct vision and there is a risk of causing morbidity or the block not being effective. It is much easier for a surgeon to apply the block, as they can see the anatomical landmarks. Despite this, very few surgeons are aware of the technique. The study group consists of patients undergoing bilateral cosmetic breast surgery at BMI Edgbaston and Priory hospitals and Spire Parkway and Southbank hospitals in Birmingham and Worcester. If a patient consents to being involved in the research, they will have one breast randomised to receiving a pec block and the contralateral (opposite) breast will receive the same amount of local anaesthetic placed in the breast pocket in a non-targeted fashion. The patients and researcher will be blinded as to the allocation. Patients will complete a verbal numeric pain score for each breast at set intervals until they are discharged.In addition, the investigators will specifically ask which breast is the most painful at each time point. The results of the study may improve patient care.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2016

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 31, 2015

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 8, 2015

Completed
9 months until next milestone

Study Start

First participant enrolled

January 1, 2016

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2016

Completed
Last Updated

July 26, 2016

Status Verified

July 1, 2016

Enrollment Period

8 months

First QC Date

March 31, 2015

Last Update Submit

July 23, 2016

Conditions

Keywords

painsurgery

Outcome Measures

Primary Outcomes (1)

  • targeted question as to which breast is more painful

    patient is asked which breast is more painful

    3 hours post-operatively

Secondary Outcomes (1)

  • verbal numeric rating scale(VNRS)

    3 hours post-operatively

Study Arms (2)

standard chirocaine infiltration

ACTIVE COMPARATOR

non-targeted infiltration of 10ml 0.25% Chirocaine into breast pocket

Other: standard chirocaine infiltrationOther: standard post-operative analgesia

targeted chirocaine pec block

EXPERIMENTAL

pectoral muscle block with 10ml 0.25% chirocaine

Other: targeted chirocaine pec blockOther: standard post-operative analgesia

Interventions

10ml 0.25% chirocaine in a specifically targeted in a nerve block

Also known as: Pectoral nerve block
targeted chirocaine pec block

10ml 0.25% chirocaine is infiltrated into breast pocket in a non targeted fashion

Also known as: intra-operative analgesia
standard chirocaine infiltration

A dose of morphine 0.1mg/kg will be given intra-operatively. Thereafter morphine 0.1mg/kg will be given for breakthrough pain. Patients will be prescribed regular paracetamol and ibuprofen.

Also known as: Morphine, Paracetamol, ibuprofen, analgesia
standard chirocaine infiltrationtargeted chirocaine pec block

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient requesting a bilateral breast procedure (reduction, mastopexy or augmentation).
  • Patient willing to sign the informed consent form agreeing to its items after explanation of the study by the operating surgeon.

You may not qualify if:

  • Declining to give written consent.
  • History of allergy to chirocaine local anaesthetic.
  • Prior breast surgery.
  • Chronic pain disorder.
  • Significant medical co-morbidities.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Edgbaston BMI Hospital

Birmingham, West Midlands, B152QQ, United Kingdom

RECRUITING

MeSH Terms

Conditions

Pain, PostoperativePain

Interventions

MorphineAcetaminophenIbuprofenAnalgesia

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

Morphine DerivativesMorphinansOpiate AlkaloidsAlkaloidsHeterocyclic CompoundsHeterocyclic Compounds, Bridged-RingHeterocyclic Compounds, 4 or More RingsHeterocyclic Compounds, Fused-RingPhenanthrenesPolycyclic Aromatic HydrocarbonsPolycyclic CompoundsAcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAminesPhenylpropionatesAcids, CarbocyclicCarboxylic AcidsAnesthesia and Analgesia

Study Officials

  • anne dancey, MBChB(hons)

    AAS

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Anne Dancey, MBChB(Hons)

CONTACT

Louise Maclennan, MBChB

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Consultant Plastic Surgeon

Study Record Dates

First Submitted

March 31, 2015

First Posted

April 8, 2015

Study Start

January 1, 2016

Primary Completion

September 1, 2016

Study Completion

September 1, 2016

Last Updated

July 26, 2016

Record last verified: 2016-07

Data Sharing

IPD Sharing
Will share

yes on individual request of the patient when study is completed

Locations